EN
HI
Kilitch Drugs (India) Chart
Kilitch Drugs (India) Share Key Metrics
Volume
93019.00
Market Cap
643.61 CR
LTQ@LTP
50@184.09
ATP
187.16
Var Margin
22.26 %
Circuit Range
151.23-226.83
Delivery %
47.44 %
Value
1.74 CR
ASM/GSM
No
Market Lot
1
Summary
Kilitch Drugs (India) share price is ₹184.09 as of 15 Jun, 2026. The stock Kilitch Drugs (India) intraday movement has stayed between ₹182.21 and ₹193.75, while on a 52-week basis,Kilitch Drugs (India) price 52 week high is ₹250.00 & its 52 week low is ₹117.25.
In terms of trading activity, Kilitch Drugs (India) has recorded a volume of 93019 shares, The Kilitch Drugs (India) has a market cap of ₹34961564 CR. The stock’s Average Traded Price (ATP) stands at ₹187.16, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹184.09.
Kilitch Drugs (India) operates within a circuit range of ₹151.23 – ₹226.83, with a Value of ₹1.74 CR. The Delivery Percentage for the day is 47.44%. Additionally, Kilitch Drugs (India) currently falls under the No framework, and trades with a market lot size of 1.
Kilitch Drugs (India) Fundamentals
P/E Ratio
20.98
P/B Ratio
2.26
Div. Yield
0
Sector P/E
69.77
Sector P/B
2.99
Sec. Div. Yield
0.54
Kilitch Drugs (India) Resistance and Support
Pivot 187.46
Resistance
First Resistance
193.44
Second Resistance
197.84
Third Resistance
203.82
Support
First Support
183.06
Second Support
177.08
Third Support
172.68
Kilitch Drugs (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-15 | Audited Results |
| 2026-02-11 | Quarterly Results & Bonus issue |
| 2025-11-13 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-11 | Quarterly Results |
Kilitch Drugs (India) News
Kilitch Drugs India Ltd - 524500 - Board Meeting Outcome for Submission Of Audited Standalone And Consolidated Financial Results For The Quarter Ended 31St March, 2026
Kilitch Drugs' board approved Q4 FY26 audited standalone revenue of ₹71.97 cr (up 27.8% YoY) and net profit of ₹14.00 cr (up 23.1% YoY). Consolidated revenue rose 46.3% to ₹89.60 cr and net profit increased 45.6% to ₹14.88 cr for the quarter. The company also issued 1:1 bonus shares on March 25, 2026.
May 15 2026 19:11:41
Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Kilitch Drugs (India) Ltd. reported that ₹1.12 crore from its Rights Issue proceeds, earmarked for capital expenditure, remains unutilized. The deployment, originally scheduled by March 31, 2026, is now expected by Q1FY27 due to a pending final inspection of the greenfield project.
May 15 2026 18:49:13
Kilitch Drugs (India) Management
| Name | Position |
|---|---|
| Pushpa Nyoupane | Company Secretary & Compliance Officer |
| Mukund P Mehta | Managing Director |
Kilitch Drugs (India) Similar Stocks
Anlon Healthcare Ltd.
15.24
0.18 (1.20%)
Sigachi Industries Ltd.
21.41
0.77 (3.73%)
Unihealth Hospitals Ltd.
496.95
23.65 (5.00%)
Gaudium IVF and Women Health Ltd.
101.53
1.99 (2.00%)
Hexagon Nutrition Ltd.
53.19
2.53 (4.99%)
Zim Laboratories Ltd.
111.82
-2.57 (2.25%)
Chandan Healthcare Ltd.
226.30
-0.50 (0.22%)
Influx Healthtech Ltd.
242.50
4.35 (1.83%)
Accent Microcell Ltd.
450.00
-9.40 (2.05%)
Kilitch Drugs (India) FAQs
The Buying Price of Kilitch Drugs (India) share is 184.09 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kilitch Drugs (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kilitch Drugs (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kilitch Drugs (India) shares is 20.98. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kilitch Drugs (India) shares is 2.26. Useful to assess the stock's value relative to its book value.
To assess Kilitch Drugs (India)’s valuation compare Sector P/E, P/B which are 69.77 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kilitch Drugs (India) is 643.61 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kilitch Drugs (India) share price is 250.00 & 117.25. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kilitch Drugs (India) belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
